1. Home
  2. INCR vs NSPR Comparison

INCR vs NSPR Comparison

Compare INCR & NSPR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Intercure Ltd.

INCR

Intercure Ltd.

HOLD

Current Price

$0.85

Market Cap

50.4M

Sector

Health Care

ML Signal

HOLD

Logo InspireMD Inc.

NSPR

InspireMD Inc.

HOLD

Current Price

$1.64

Market Cap

77.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
INCR
NSPR
Founded
1994
2005
Country
Israel
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Medical/Dental Instruments
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
50.4M
77.5M
IPO Year
2021
2009

Fundamental Metrics

Financial Performance
Metric
INCR
NSPR
Price
$0.85
$1.64
Analyst Decision
Buy
Analyst Count
0
1
Target Price
N/A
$4.00
AVG Volume (30 Days)
52.1K
17.0K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
7.32
EPS
N/A
N/A
Revenue
N/A
$2,310,000.00
Revenue This Year
$69.54
$22.91
Revenue Next Year
$41.75
$72.30
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.68
$1.51
52 Week High
$1.77
$3.34

Technical Indicators

Market Signals
Indicator
INCR
NSPR
Relative Strength Index (RSI) 45.31 40.76
Support Level $0.76 $1.62
Resistance Level $0.98 $2.51
Average True Range (ATR) 0.05 0.11
MACD 0.00 -0.01
Stochastic Oscillator 58.58 17.12

Price Performance

Historical Comparison
INCR
NSPR

About INCR Intercure Ltd.

Intercure Ltd is engaged in the research, cultivation, production, and distribution of pharma-grade cannabis-based products. Its products are available in dried inflorescences or liquid oil form, and are marketed through various brands, including Pharmo Cann, Humboldt, Indoor, Space Labs, Canndoc Utopia, Binske, Canndoc Stars, and others. The company has two operating segments, namely Investments in portfolio companies in the biomed sector and Investments in the medical cannabis sector. A majority of its revenue is generated from the Cannabis segment.

About NSPR InspireMD Inc.

InspireMD Inc is a United States based medical device company. It is focused on the development and commercialization of proprietary MicroNet stent platform technology for the treatment of complex vascular and coronary disease. The products of the company are the CGuard carotid Embolic Prevention System (CGuard EPS) and the MGuard Prime Embolic Protection System (MGuard Prime EPS). It generates the majority of the revenue from the sales of CGuard EPS which combines MicroNet and a self-expandable nitinol stent in a single device for use in carotid artery applications. The group operates in Italy, Germany, Russia and other countries.

Share on Social Networks: